Literature DB >> 16418203

Rheumatoid factors: what's new?

O M R Westwood1, P N Nelson, F C Hay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16418203     DOI: 10.1093/rheumatology/kei228

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  19 in total

1.  The frequency of antibodies against cyclic citrullinated peptides and rheumatoid factor in healthy population: a field study of rheumatoid arthritis from northern Turkey.

Authors:  Turker Tasliyurt; Bunyamin Kisacik; Suheyla Uzun Kaya; Beytullah Yildirim; Yavuz Pehlivan; Faruk Kutluturk; Huseyin Ozyurt; Semsettin Sahin; Ahmet Mesut Onat
Journal:  Rheumatol Int       Date:  2012-07-25       Impact factor: 2.631

2.  Prevalence of positive autoimmune biomarkers in the brucellosis patients.

Authors:  Zahra Ahmadinejad; Alireza Abdollahi; Vahid Ziaee; Zeinab Domiraei; Seyed-Reza Najafizadeh; Sirus Jafari; Mahdi Ahmadinejad
Journal:  Clin Rheumatol       Date:  2016-01-19       Impact factor: 2.980

3.  Socioeconomic inequality in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Nader Salari; Mohsen Kazeminia; Shamarina Shohaimi; Masoud Mohammadi
Journal:  Clin Rheumatol       Date:  2021-06-22       Impact factor: 2.980

4.  A comparison of performance of anti-cyclic citrullinated peptide 2 and citrullinated protein antibodies in the diagnosis of rheumatoid arthritis in Iranian patients.

Authors:  Elham Aflaky; Saeedeh Shenavandeh; Mohammad Javad Ashraf
Journal:  Rheumatol Int       Date:  2009-08-12       Impact factor: 2.631

5.  Rheumatoid factor isotype and Ro epitope distribution in primary Sjögren syndrome and rheumatoid arthritis with keratoconjunctivitis sicca.

Authors:  Bob Meek; Johannes C Kelder; Anke M E Claessen; Arend Jan van Houte; Evert-Jan Ter Borg
Journal:  Rheumatol Int       Date:  2018-06-23       Impact factor: 2.631

6.  Anticyclic citrullinated peptide antibody and rheumatoid factor in south Tunisian patients with rheumatoid arthritis: association with disease activity and severity.

Authors:  Mariem Ben Hamad; Sameh Marzouk; Neila Kaddour; Hatem Masmoudi; Faiza Fakhfakh; Ahmed Rebai; Zouhir Bahloul; Abdellatif Maalej
Journal:  J Clin Lab Anal       Date:  2013-12-27       Impact factor: 2.352

7.  Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies.

Authors:  Cristina Regueiro; Laura Nuño; Ana Triguero-Martinez; Ana M Ortiz; Alejandro Villalba; María Dolores Bóveda; Ana Martínez-Feito; Carmen Conde; Alejandro Balsa; Isidoro González-Alvaro; Antonio Gonzalez
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

Review 8.  Biomarkers in Rheumatoid Arthritis.

Authors:  Samantha C Shapiro
Journal:  Cureus       Date:  2021-05-16

Review 9.  Rheumatoid factors: clinical applications.

Authors:  Francesca Ingegnoli; Roberto Castelli; Roberta Gualtierotti
Journal:  Dis Markers       Date:  2013-11-13       Impact factor: 3.434

10.  Prevalence of anti-Neu5Gc antibodies in patients with hypothyroidism.

Authors:  Phaedra Eleftheriou; Stavros Kynigopoulos; Alexandra Giovou; Alexandra Mazmanidi; John Yovos; Petros Skepastianos; Eleni Vagdatli; Christos Petrou; Dafni Papara; Maria Efterpiou
Journal:  Biomed Res Int       Date:  2014-06-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.